We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

603228:SSEShenzhen Kinwong Electronic Co., Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥61.06

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shenzhen Kinwong Electronic is trading at CNY 61.06, just below its 20‑day SMA of 63.24 and well under the 50‑day SMA of 67.05, signaling a short‑term pull‑back despite a neutral 200‑day SMA position at 59.12. The RSI of 43 and a bearish MACD histogram (-0.0115) reinforce the near‑term downside bias, while the stock sits near its technical support of 56.41 and faces resistance around 70.77. Fundamentally, the company posts a robust 24% revenue growth and a modest 8.3% profit margin, yet its forward PE of 35.9 remains well above the industry average of 34.2, indicating an overvalued price relative to peers. The dividend yield of 1.26% with a 60% payout ratio is attractive, but negative free cash flow (-518.8 M) and a high debt‑to‑equity ratio (16.2) raise sustainability concerns. Volatility is elevated at 44.6% over the past 30 days, though a low beta of 0.44 suggests limited market‑wide price swings. Overall, the stock presents a mixed picture: strong top‑line growth and dividend appeal offset by valuation premium, cash flow weakness, and heightened price volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and price below short‑term SMA
  • High valuation multiples vs industry
  • Elevated 30‑day volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong 24% revenue growth trajectory
  • Attractive dividend yield with reasonable payout
  • Improving forward PE relative to current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular demand for PCBs in automotive and telecom
  • Solid cash position offsetting debt load
  • Potential for valuation re‑rating as cash flow improves

Key Metrics & Analysis

Financial Health

Revenue Growth24.20%
Profit Margin8.27%
P/E Ratio46.3
ROE10.14%
ROA3.54%
Debt/Equity16.22
P/B Ratio4.7
Op. Cash FlowCN¥1.9B
Free Cash FlowCN¥-518842272
Industry P/E34.2

Technical Analysis

TrendNeutral
RSI43.4
SupportCN¥56.41
ResistanceCN¥70.77
MA 20CN¥63.24
MA 50CN¥67.05
MA 200CN¥59.12
MACDBearish
VolumeStable
Fear & Greed Index79.45

Valuation

Fair ValueCN¥50.72
GradeOvervalued
TypeBlend
Dividend Yield1.26%

Risk Assessment

Beta0.44
Volatility44.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.